Home › Heart Attack › Connecticut › Hartford
Heart Attack clinical trials in Hartford, CT
4 studies for Heart Attack are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Greater Hartford Nephrology, LLC, Bloomfield · 5 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Hartford Hospital, Hartford
Circulating Markers for Ischemic Heart Disease
RecruitingObservational studyHealthy volunteers welcome
- University of Connecticut Health Center, Farmington · 8 mi away
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RecruitingObservational studyHealthy volunteers welcome
- University of Connecticut Health Center, Farmington · 8 mi away
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- New York City, NY6 studies
- Dallas, TX6 studies
- Rochester, MN6 studies
- Boston, MA5 studies
- Detroit, MI4 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Nashville, TN4 studies
- Boca Raton, FL4 studies
- Knoxville, TN4 studies
- Greensboro, NC3 studies
- Austin, TX3 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Cancer (all types)10 studies
- Breast Cancer9 studies
- Major Depressive Disorder9 studies
- Neuroblastoma8 studies
- Multiple Myeloma7 studies
- Cardiovascular Disease7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Ovarian Cancer7 studies
- Heart Failure7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.